OrthoPediatrics Corp. 8-K Summary
Business Context and Reporting Period
OrthoPediatrics Corp. (Nasdaq: KIDS) filed a Form 8-K on October 28, 2025, to report its financial results for the quarter ended September 30, 2025. The company is incorporated in Delaware and operates from Warsaw, Indiana.
Key Financial Metrics
This filing serves as a notification of the earnings release and incorporates the detailed financial data by reference in Exhibit 99.1. The text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release (Exhibit 99.1) for these figures.
Material Changes
The filing does not contain specific data regarding material changes compared to the prior period. Such comparisons are contained within the unaudited condensed consolidated financial statements referenced in Exhibit 99.1.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are detailed in the press release dated October 28, 2025, which is incorporated by reference. This 8-K text does not explicitly list unusual items or specific outlook statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q3 2025 revenue and net income figures.
- Verify year-over-year growth rates and margin trends in the attached financial statements.
- Check the press release for any updated full-year 2025 guidance or outlook.
- Confirm liquidity position and debt covenants in the unaudited condensed consolidated balance sheet.